Skip to main content

Table 3 Global and regional myocardial strain parameters for HHD and healthy control groups

From: Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain

 HHD(n = 62)Controls
(n = 26)
P value
EF < 30%
(n = 22)
30%EF < 50%
(n = 18)
EF50
(n = 22)
RS
 Global8.2 ± 2.913.8 ± 4.329.1 ± 6.035.6 ± 7.5< 0.01a b c e d f
 Base9.6 (7.3)16.9 (10.4)(14.5817.39)30.4 (17.0)43.2 (17.0)< 0.05a b e f
 Middle6.6 (4.0)10.3 (5.2)25.4 (8.9)31.9 (14.2)< 0.01a b e f
 Apex8.6 ± 5.913.7 ± 3.931.3 ± 11.136.2 ± 10.9< 0.01a b e f
CS
 Global−7.1 (3.2)−10.1 (3.2)−19.6 (4.8)−20.5 (4.1)< 0.01a b e f
 Base−6.5 (2.5)−10.1 (3.2)−17.5 (5.8)−18.9 (3.8)< 0.01a b e f
 Middle−6.2 (3.0)−10.8 (3.3)−20.2 (3.9)−20.7 (4.2)< 0.01a b e f
 Apex−9.2 (4.9)−12.6 (5.1)−22.5 (5.2)(24.74)−22.8 (5.3)(23.29)< 0.01a b e f
LS
 Global−4.0 (2.9)−6.5 (2.4)−12.1 (3.8)−14.9 (3.6)< 0.05 a b e f
 Base−2.7 (7.3)−4.7 (4.5)−10.4 (6.2)−12.6 (4.8)< 0.05 a b e f
 Middle−3.7 (3.2)−6.5 (3.6)−12.1 (6.0)−14.2 (4.7)< 0.05 a b e f
 Apex−5.4 (2.9)−10.0 (3.0)−14.9 (3.4)(35.55)−17.9 (4.1)< 0.05 a b e f
  1. Abbreviations: a EF < 30% compared with Controls; b 30%EF < 50% compared with Controls; c EF50 compared with Controls; d EF < 30% compared with 30%EF < 50%; e EF < 30% compared with EF50; f 30%EF < 50% compared with EF50